Recent prescription status of oral analgesics in Japan in real-world clinical settings: retrospective study using a large-scale prescription database

被引:25
作者
Ushida, Takahiro [1 ]
Matsui, Daiju [2 ]
Inoue, Teruyoshi [2 ]
Yokoyama, Mizuka [2 ]
Takatsuna, Hiroshi [2 ]
Matsumoto, Takuyuki [3 ]
Takita, Atsushi [4 ]
Kurusu, Takao [5 ]
Sakoda, Hiroshi [2 ]
Okuizumi, Kaoru [2 ]
机构
[1] Aichi Med Univ, Multidisciplinary Pain Ctr, Nagakute, Aichi, Japan
[2] Daiichi Sankyo Co Ltd, Med Sci Dept, Med Affairs Div, Tokyo, Japan
[3] Daiichi Sankyo Co Ltd, Safety & Risk Management Dept, Qual & Safety Management Div, Tokyo, Japan
[4] Daiichi Sankyo Co Ltd, R&D Div, Biostat & Data Management Dept, Tokyo, Japan
[5] Japan Med Informat Res Inst Inc, Data Solut Div, Rx Grp, Tokyo, Japan
关键词
Retrospective study; large-scale database; prescription status; oral analgesics; co-prescription patterns; loxoprofen; ANTIHYPERGLYCEMIC DRUGS; SAFETY; ASSOCIATION; CELECOXIB; ALERT; PAIN;
D O I
10.1080/14656566.2019.1651840
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Information on prescriptions of oral analgesics for the treatment of pain is beneficial. However, there have been few reports on the prescription status of oral analgesics from a nation-wide, large-scale prescription database in Japan. Research design and methods: The authors analyzed the prescription data of 2,042,302 patients prescribed oral analgesics in 2017. The numbers/proportions of patients prescribed oral analgesics, adherence with approved doses, co-prescription patterns, dose changes, drug adherence, and treatment-discontinuation rates were evaluated. Results: Loxoprofen was prescribed to 32.5% of the patients, followed by celecoxib, prescribed to 16.0% of patients. Acetaminophen and pregabalin were prescribed to 10.5% and 9.4% of patients, respectively. Many analgesics were prescribed at lower doses than the approved doses. The most frequently used concomitant medication was pregabalin. For duloxetine and pregabalin, high proportions of patients were prescribed these drugs for > 90 days. Conclusions: Loxoprofen was the most prescribed of the non-steroidal anti-inflammatory drugs in Japan. The information obtained provides an overview of prescribed oral analgesics in Japan and could be useful for potential research into prescribed oral analgesics in the future.
引用
收藏
页码:2041 / 2052
页数:12
相关论文
共 36 条
  • [1] [Anonymous], WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects
  • [2] [Anonymous], 2014, GUIDELINE IMPLEMENTA
  • [3] Astellas Pharma Inc, CEL CEL TABL 100MG 2
  • [4] AYUMI Pharmaceutical Co, CALONAL AC PACK INS
  • [5] Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
    Bresalier, RS
    Sandler, RS
    Quan, H
    Bolognese, JA
    Oxenius, B
    Horgan, K
    Lines, C
    Riddell, R
    Morton, D
    Lanas, A
    Konstam, MA
    Baron, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) : 1092 - 1102
  • [6] Committee on the Guidelines for Pain Treatment the Japanese Society of Pain Clinicians, 2016, GUID PAIN TREATM VER
  • [7] Daiichi Sankyo Co. Ltd, LOX LOX TABL FIN GRA
  • [8] Daiichi Sankyo Espha Co. Ltd, TOAR COMB TABL DSEP
  • [9] Eli Lilly Japan K. K, CYMB DUL CAPS PACK I
  • [10] Loxoprofen: A Review in Pain and Inflammation
    Greig, Sarah L.
    Garnock-Jones, Karly P.
    [J]. CLINICAL DRUG INVESTIGATION, 2016, 36 (09) : 771 - 781